Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mutimodal Artificial Intelligence for Optimising Renal Tumour Management: Diagnosis, Surgery and Prognosis

NCT06714916 is registered in ClinicalTrials.gov with Shao Pengfei as lead sponsor.

NCT NCT06714916
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06714916 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mutimodal Artificial Intelligence for Optimising Renal Tumour Management: Diagnosis, Surgery and Prognosis
Lead sponsor
Shao Pengfei
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2025
Completion date
December 31, 2033
Enrollment
2,100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pathology, renal cell cancer, renal neoplasms